Value Added Technology Co., Ltd. (KOSDAQ:043150)
South Korea
· Delayed Price · Currency is KRW 20,900
+650 (3.21%)
Apr 1, 2025, 3:30 PM KST
Value Added Technology Revenue
In the year 2024, Value Added Technology had annual revenue of 385.19B KRW with 0.06% growth. Value Added Technology had revenue of 101.71B in the quarter ending December 31, 2024, a decrease of -2.56%.
Revenue
385.19B
Revenue Growth
+0.06%
P/S Ratio
0.81
Revenue / Employee
1.34B
Employees
287
Market Cap
310.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 385.19B | 249.51M | 0.06% |
| Dec 31, 2023 | 384.95B | -10.11B | -2.56% |
| Dec 31, 2022 | 395.06B | 56.08B | 16.54% |
| Dec 31, 2021 | 338.98B | 94.67B | 38.75% |
| Dec 31, 2020 | 244.31B | -27.39B | -10.08% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |